General Information
Hanmi DM2 204
A Phase II, 16-week, double-blind, placebo-controlled, parallel-group, randomised, multicentre trial to assess effect on glycaemic control of three doses of HM11260C in subjects with inadequately controlled type 2 diabetes receiving a stable dose of metformin
| Protocol | HM-EXC-204 |
|---|---|
| Identifier | HM-EXC-204 Site Number 3517 |
| UID | d315bbd2-3bc6-41ba-b9d4-15899db1dad2 |
| Status | Done - Archived |
| Phase | 2 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2014 |
| NCT Number | - |
| Created | 2014-01-29 12:57 |
| Last Updated | 2014-01-29 12:57 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2014-10-29 | No |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2014-02-25 | No |
| PI Meeting Start | 2014-02-08 | No |
| PI Meeting End | 2014-02-08 | No |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2015-07-07 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Pereira, Cynthia | CPereira | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Hanmi Pharmaceuticals Co. Ltd |
|---|---|
| Division | Hanmi Pharmaceuticals Co. Ltd |
| Team | Hanmi Pharmaceuticals Co. Ltd |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | PRA (NC) |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
